M&A (Fusiones y adquisiciones) futuro...

The past twelve months have been a very active time for pharmaceutical companies interested in pursuing an acquisition or a company sale.

The lagging economy has created a market where cash depraved companies, generally small and mid-sized, put themselves on the selling block for tokens on the dollar, and where the industry giants snap them up without making a dent in their cash reserves.The venture capital and private investment firms are lending less and credit has deteriorated.

.../...

The single most important issue, as seen in Figure, is the certainty that small companies will soon start running out of operating capital. As more and more firms face the prospect of closing their doors, observers predict M&A bargains for companies that can afford them. However, the factor mentioned next by survey respondents – restricted access to credit – may hamper some of those acquisition plans. Navigating the coming year will prove challenging, teams say, but opportunities will emerge as the global economy slowly improves, credit markets reopen and companies hunt for deals.


Ultimas "movidas..."

Click sobre imagen para ampliar